Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Managing Partnerships with CROs

03 Oct 2012 - 04 Oct 2012 - London, UK



Bookmark and Share


The event offers the unique opportunity to hear from representatives from Pharma, CRO and Academia with an emphasis on improving communication and creating strong and successful partnerships between all parties.

Key benefits of attending:

Learn from industry specialists what current issues are facing those working within sponsor CRO relationships. 

Understand what causes breakdown in relationships and ways to prevent this through real case studies. 

Hear from speakers on both sides of the relationship, and their strategies for developing successful partnership.

Discuss the strategic rationale for clinical development outsourcing among the large pharmaceutical companies

Two highly rated workshops, Peter Volker from Booz & Co the company that recently released a highly rated report with CRO ICON. Dr. Volker will discuss key issues on preparing for partnership and engagement models and success factors and Graeme Ladds who has worked with CROs for many years had developed his workshop to touch upon points for success, strategy for maintaining quality and multinational multiproduct outsourcing.

For more information visit http://www.smi-online.co.uk/goto/pharmaoutsourcingevent9.asp

Or Contact Fateja Begum on fbegum@smi-online.co.uk or tel +44 0 207 827 6184



Further information
Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!